INSM - NASDAQ

Insmed Incorporated

INSM·NASDAQ

$103.86

+0.13%

HealthcareBiotechnology

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$22.51B

EPS-6.4100

P/E Ratio-16.20

Earnings Date08/06/2026

insm

Long Term Investments

Last Annual Value

0.00

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Insmed Incorporated Competitors Analysis of Long Term Investments

INSM · NASDAQ

Company	Long Term Investments	CAGR 3Y	CAGR 5Y	CAGR 10Y
Insmed Incorporated NASDAQ:INSM	0.00	N/A	N/A	N/A
ResMed Inc. NYSE:RMD	85.03M	-18.5%	2.4%	9.7%
GE HealthCare Technologies Inc. NASDAQ:GEHC	0.00	N/A	N/A	N/A
Humana Inc. NYSE:HUM	16.83B	-1.7%	3.6%	22.6%
Agilent Technologies, Inc. NYSE:A	133.00M	-6.7%	-6.4%	-0.1%
Cardinal Health, Inc. NYSE:CAH	14.00M	-37.0%	-27.1%	N/A
IQVIA Holdings Inc. NYSE:IQV	432.00M	21.8%	21.4%	18.1%
BeOne Medicines Ltd. NASDAQ:ONC	82.51M	-2.7%	-3.9%	N/A

Insmed Incorporated Fair Value Envelope

INSM · NASDAQ

Our analysis suggests that INSM has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $103.86, this represents a potential HIDDEN relative to our calculated worth for Insmed Incorporated.

HIDDEN

Intrinsic Value

Current Price: $103.86

Related Guides

Blog Categories

Continue your INSM research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.